A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood
Clinical trial NCT03082183 · COMPLETED
Trial details
- NCT number
- NCT03082183
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-28
- Primary completion
- 2017-06-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.